Browse Negotiations Image Banner

Banner Text Velit velaliquam, ultricies eros dolore magna in in doming ullamco sint. Sint doming dignissim in quis pariatur consequat urna eu providerent. Sint dolore ea urna velit doming ea pulvinar.

General Callout

Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.

Accordion

Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.

Heading 1

Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.

Heading 2

Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.

Related content

Dolor commodo suscipit adipiscing suscipit, elit dolore velit. Amet tempuribud velit pariatur ullamco exercitation esse dolore sint velaliquam adipiscing eu pulvinar doming sunt, dignissim velit voluptate ex suscipit sunt ex, duis dignissim nunc tempuribud laboris commodo velit ut. Velit in harmud quis voluptate esse nulla.

Shop Now!

Laboris quis consectetur sed eros velit tempuribud suscipit magna ea consequat laboris. Elit adipiscing quis sunt duis magna nulla velit amet elit ex providerent consectetur tempuribud amet ex commodo urna, magna adipiscing elit sed duis nisi pulvinar, doming pariatur velaliquam quis providerent fugiat ea aliquip sit ut nisi sunt pulvinar eu velit.

grey rec centre

Call to action

Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate

Primary Button Secondary Button

Search by drug, manufacturer, or indication

Displaying 811 - 820 of 1165

Onivyde (irinotecan liposome)

Status:

Concluded without agreement

Manufacturer:

Servier Canada Inc.

Indication:

Metastatic Pancreatic Cancer

Last updated June 7, 2019

Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)

Status:

Concluded without agreement

Manufacturer:

Janssen Inc.

Indication:

HIV-1 Infection

Last updated May 22, 2019

Viacoram (perindopril arginine/amlodipine)

Status:

Concluded without agreement

Manufacturer:

Servier Canada Inc.

Indication:

Hypertension

Last updated May 22, 2019

Adcetris (brentuximab vedotin)

Status:

Negotiations were not pursued

Manufacturer:

Seattle Genetics Inc.

Indication:

Hodgkin's Lymphoma

Last updated May 17, 2019

Fasenra (benralizumab)

Status:

Concluded with an LOI

Manufacturer:

AstraZeneca Canada Inc.

Indication:

Eosinophilic Asthma

Last updated May 3, 2019

Probuphine (buprenorphine)

Status:

Concluded with an LOI

Manufacturer:

Knight Therapeutics Inc.

Indication:

Opioid Use Disorder

Last updated May 3, 2019

Kisqali (ribociclib)

Status:

Concluded with an LOI

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Indication:

Advanced or Metastatic Breast Cancer

Last updated April 26, 2019

Akynzeo (netupitant/palonosetron)

Status:

Concluded with an LOI

Manufacturer:

Purdue Pharma

Indication:

Nausea and vomiting (chemotherapy induced) prevention

Last updated April 24, 2019

Duodopa (levodopa/carbidopa)

Status:

Concluded with an LOI

Manufacturer:

AbbVie Corporation

Indication:

Parkinson's disease

Last updated April 18, 2019

Eucrisa (crisaborole)

Status:

Negotiations were not pursued

Manufacturer:

Pfizer Canada ULC

Indication:

Atopic dermatitis

Last updated April 16, 2019